World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
10877
World Ranking
4184
National Ranking
1622

Mary Patricia Nowalk publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mary Patricia Nowalk sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 269 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mary Patricia Nowalk D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mary Patricia Nowalk sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 52 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mary Patricia Nowalk is affiliated with the University of Pittsburgh in the United States. Their research primarily focuses on medicine with an emphasis on epidemiology, infectious diseases, and public health.

Their contributions span multiple subfields of study including:

  • Epidemiology
  • Infectious Diseases
  • Health
  • Modeling and Simulation
  • Immunology

Their major research topics include:

  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 Research
  • Pneumonia and Respiratory Infections
  • Vaccine Coverage and Hesitancy
  • COVID-19 epidemiological studies
  • COVID-19 Clinical Research Studies

Mary Patricia Nowalk has published extensively with notable frequent co-authors such as Richard K. Zimmerman, Manjusha Gaglani, Emily T. Martin, Brendan Flannery, and Jessie R. Chung, reflecting ongoing collaborations in their research community.

Their work has appeared mostly in venues specializing in vaccine and infectious disease research. Some frequent publication outlets include:

  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Influenza and Other Respiratory Viruses
  • Human Vaccines & Immunotherapeutics

Recent papers authored or co-authored by Mary Patricia Nowalk demonstrate a focus on vaccine effectiveness and respiratory infections:

  • Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021, 2021, MMWR Morbidity and Mortality Weekly Report
  • Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020, MMWR Morbidity and Mortality Weekly Report
  • Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020, 2020, Clinical Infectious Diseases
  • Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season, 2020, Clinical Infectious Diseases
  • Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022, MMWR Morbidity and Mortality Weekly Report

Best Publications

  • Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

    Suzanne E. Ohmit;Mark G. Thompson;Joshua G. Petrie;Swathi N. Thaker

  • Vaccine criticism on the World Wide Web.

    Richard K Zimmerman;Robert M Wolfe;Dwight E Fox;Jake R Fox

  • Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata

    Richard Kent Zimmerman;Mahlon Raymund;Janine E Janosky;Mary Patricia Nowalk

  • Influenza vaccine effectiveness in the United States during the 2015-2016 season.

    Michael L. Jackson;Jessie R. Chung;Lisa A. Jackson;C. Hallie Phillips

  • Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type

    Huong Q. McLean;Mark G. Thompson;Maria E. Sundaram;Burney A. Kieke

  • Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season.

    Melissa A Rolfes;Brendan Flannery;Jessie R Chung;Alissa O'Halloran

  • 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

    Richard K Zimmerman;Mary Patricia Nowalk;Jessie Chung;Michael L Jackson

  • What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and veterans affairs practices

    Richard Kent Zimmerman;Tammy A Santibanez;Janine E Janosky;Michael J Fine

  • Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.

    Mark W. Tenforde;Samantha M. Olson;Wesley H. Self;H. Keipp Talbot

  • Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015

    Brendan Flannery;Jessie Clippard;Richard K. Zimmerman;Mary Patricia Nowalk

  • Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

    Brendan Flannery;Jessie R. Chung;Edward A. Belongia;Huong Q. McLean

  • Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.

    Brendan Flannery;Rebecca J Garten Kondor;Jessie R Chung;Manjusha Gaglani

  • Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States

    Manjusha Gaglani;Jessica Pruszynski;Kempapura Murthy;Lydia Clipper

  • Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons.

    Fiona P. Havers;Lauri A. Hicks;Jessie R. Chung;Manjusha Gaglani

  • Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine

    Kenneth J. Smith;Angela R. Wateska;Mary Patricia Nowalk;Mahlon Raymund

  • Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.

    Fatimah S. Dawood;Jessie R. Chung;Sara S. Kim;Richard K. Zimmerman

  • Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.

    Brendan Flannery;Swathi N. Thaker;Jessie Clippard;Arnold S. Monto

  • Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

    Brendan Flannery;Richard K. Zimmerman;Larisa V. Gubareva;Rebecca J. Garten

  • Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.

    Jessie R. Chung;Brendan Flannery;Mark G. Thompson;Manjusha Gaglani

  • Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season

    Brendan Flannery;Jessie R Chung;Arnold S Monto;Emily T Martin

  • Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study

    N.Carole Milas;Mary Patricia Nowalk;Lillie Akpele;Lori Castaldo

  • Early estimates of seasonal influenza vaccine effectiveness - United States, January 2013

    Lisa Jackson;Michael L. Jackson;C. Hallie Phillips;Joyce Benoit

Frequent Co-Authors

Richard K. Zimmerman
Richard K. Zimmerman University of Pittsburgh
Manjusha Gaglani
Manjusha Gaglani Baylor College of Medicine
Brendan Flannery
Brendan Flannery Centers for Disease Control and Prevention
Edward A. Belongia
Edward A. Belongia Marshfield Clinic
Huong Q. McLean
Huong Q. McLean Marshfield Clinic
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Arnold S. Monto
Arnold S. Monto University of Michigan–Ann Arbor
Alicia M. Fry
Alicia M. Fry Emory University
Emily T. Martin
Emily T. Martin University of Michigan–Ann Arbor
Manish M. Patel
Manish M. Patel Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various interdisciplinary careers that combine science with healthcare and technology. For example, those interested in patient-centered roles might consider becoming a certified child life specialist salary professionals, who support children during medical treatments using specialized knowledge.

Additionally, students looking for flexible, affordable programs often explore degrees for felons, enabling second chances through accessible online education options.

Health-focused pathways like functional medicine nurse practitioner programs offer specialized training that integrates holistic care strategies, combining microbiology knowledge with patient treatment.

Beyond clinical roles, microbiology graduates may also consider careers in medical coding, with opportunities like becoming a certified professional coder (cpc), a critical position in healthcare documentation and billing.

These diverse online degrees and career pathways demonstrate the broad applicability of microbiology education across modern healthcare and scientific industries.

Best Scientists Citing Mary Patricia Nowalk

Trending Scientists

Recently Published Articles